|Title:||Clinical efficacy of a betablockers therapy in patients with chronic heart failure on the background of postinfarction cardiosclerosis|
|Authors:||Osipova, O. A.|
Kulikovskii, V. F.
Plaksina, K. G.
Shabanov, E. A.
Gosteva, E. V.
chronic heart failure
|Citation:||Clinical efficacy of a betablockers therapy in patients with chronic heart failure on the background of postinfarction cardiosclerosis / O. A. Osipova [и др.] // Research result. Pharmacology and clinical pharmacology. - 2017. - Vol.3, №1.-P. 90-96. - DOI : 10.18413/2500-235X-2017-3-1-90-96. - Refer.: p. 95-96.|
|Abstract:||Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acute myocardial infarction (AMI), the comparative effectiveness of various BBs in patients with postinfarction cardiosclerosis (PICS) is uncertain. There was performed comparative analysis of clinical efficacy of BBs in patients with chronic heart failure (CHF) on the background of coronary heart disease (CHD), PICS. There was evaluated the impact of metoprolol succinate, carvedilol, bisoprolol and betaxolol on blood pressure (BP), left ventricular ejection fraction (LVEF), change the functional class of chronic heart failure, and mortality in patients over 4 years|
|Appears in Collections:||Research Result. Pharmacology and Clinical Pharmacology|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.